Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
JNJ-75348780 for Lymphoma and Leukemia
Recruiting1 awardPhase 1
Oklahoma City, Oklahoma
This trial is testing a new drug for people with relapsed or refractory B-cell NHL or CLL. The goal is to find the best dose and schedule for the drug and to characterize its safety.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.